Your browser doesn't support javascript.
loading
Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
Yamazaki, Takao; Desai, Amit; Han, David; Kato, Kota; Kowalski, Donna; Akhtar, Shahzad; Lademacher, Christopher; Kovanda, Laura; Townsend, Robert.
  • Yamazaki T; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Desai A; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Han D; PAREXEL, Los Angeles, CA, USA.
  • Kato K; Analysis & Pharmacokinetics Research Laboratories, Astellas Pharma Inc, Osaka, Japan.
  • Kowalski D; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Akhtar S; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Lademacher C; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Kovanda L; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
  • Townsend R; Astellas Pharma Global Development, Inc, Northbrook, IL, USA.
Clin Pharmacol Drug Dev ; 6(1): 93-101, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27273248
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Triazoles / Ritonavir / Lopinavir / Nitrilos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Triazoles / Ritonavir / Lopinavir / Nitrilos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article